Literature DB >> 309736

[In vitro incubation of lenses. Model for testing substrate utilization of substances of the energy metabolism, demonstrated with bencyclane-hydrogen-fumarate (author's transl)].

O Hockwin, I Korte, R Breuer, G Schmidt, F Rast-Czyborra.   

Abstract

When bovine lens homogenate was treated with bencyclane-hydrogen-fumarate, the carbohydrate metabolism was activated. This may chiefly be due to the fumarate part of the substance. A 24 H In vitro incubation of whole bovine lenses in TC-199 with and without bencyclane-hydrogen-fumarate did not show the above effect. On the model of former investigations by J.E. Harris et al. we modified the test procedure by selecting the medium and the time of incubation so that the endogenous carbohydrates of the lens were consumed, thus creating new metabolic balances. This metabolic condition allows investigations intended to activate metabolic processes and to restore the steady state of metabolic parameters. We investigated the effect of bencyclane-hydrogen-fumarate using the same method and found that given certain conditions the lens recovers when incubated for 2 h in TC-199 (containing 1 g glucose/1) with addition of a 10(-4) M solution of bencyclane-hydrogen-fumarate. The ATP-content of these lenses in particular gives proof of this result. As already observed in former investigations on homogenates, this effect is probably due to metabolization of the fumarate part of the bencyclane-hydrogen-fumarate by the citric acid cycle. The method used explains the differences observed when using lens homogenates or whole lenses under the same experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309736     DOI: 10.1007/bf00411051

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  17 in total

1.  [ON THE GLYCOGEN CONTENT IN THE LENS, LENS WALL AND LENS NUCLEUS OF CATTLE OF DIFFERENT AGES].

Authors:  O HOCKWIN; B SCHAEFER
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1964

2.  Lens metabolism as studied with the reversible cation shift. I. The role of glucose.

Authors:  J E HARRIS; J D HAUSCHILDT; L T NORDQUIST
Journal:  Am J Ophthalmol       Date:  1954-07       Impact factor: 5.258

3.  Lens metabolism as studied with the reversible cation shift. II. The effect of oxygen and glutamic acid.

Authors:  J E HARRIS; J D HAUSCHILDT; L T NORDQUIST
Journal:  Am J Ophthalmol       Date:  1954-07       Impact factor: 5.258

4.  The in vitro reversal of the lenticular cation shift induced by cold or calcium deficiency.

Authors:  J E HARRIS; L B GEHRSITZ; L NORDQUIST
Journal:  Am J Ophthalmol       Date:  1953-06       Impact factor: 5.258

5.  A REVIEW OF THE LITERATURE ON THE CRYSTALLINE LENS.

Authors:  D R Adams
Journal:  Br J Ophthalmol       Date:  1925-06       Impact factor: 4.638

6.  [The effect of fludilat on carbohydrate metabolism].

Authors:  O Hockwin
Journal:  Fortschr Med       Date:  1977-08-04

7.  The presence of glycogen in lenses of different species.

Authors:  O Hockwin
Journal:  Exp Eye Res       Date:  1973-02       Impact factor: 3.467

8.  [The dependence of various enzyme activities and substrate concentrations in cattle lenses on age].

Authors:  O Hockwin; W Licht; E Noll; M Glasmacher
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1970

9.  [Polyphosphate nucleosides of crystallin. Their development during differentiation, aging and galactose overload].

Authors:  J Klethi
Journal:  Doc Ophthalmol       Date:  1970-12-21       Impact factor: 2.379

10.  [Enzymes and intermediate products of glycogen metabolism in various parts of calf and cattle lenses].

Authors:  C Ohrloff; O Hockwin; A Holstege
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1975
View more
  1 in total

1.  Is it possible to maintain a normal glutathione level in lenses in vitro?

Authors:  O Hockwin; I Korte; E Noll; M Heiden; R Konopka; J Hagenah; R Hurtado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.